ZacksZacks

Best Momentum Stocks to Buy for July 14th

閱讀1分鐘

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 14th:

Eledon Pharmaceuticals, Inc. ELDN: This clinical stage biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 23.8% over the last 60 days.

Eledon Pharmaceuticals, Inc. Price and Consensus

Eledon Pharmaceuticals, Inc. price-consensus-chart | Eledon Pharmaceuticals, Inc. Quote

Eledon’s shares gained 22.2% over the past month compared with the S&P 500’s advance of 3.8%. The company possesses a Momentum Score of A.

Eledon Pharmaceuticals, Inc. Price

Eledon Pharmaceuticals, Inc. price | Eledon Pharmaceuticals, Inc. Quote

KDDI Corporation KDDIY: This Japanese telecommunications services company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 39.7% over the last 60 days.

KDDI Corporation Price and Consensus

KDDI Corporation Unsponsored ADR price-consensus-chart | KDDI Corporation Unsponsored ADR Quote

KDDI’s shares gained 5.9% over the last six months compared with the S&P 500’s advance of 5.2%. The company possesses a Momentum Score of B.

KDDI Corporation Price

KDDI Corporation Unsponsored ADR price | KDDI Corporation Unsponsored ADR Quote

Penguin Solutions, Inc. PENG: This designer and developer of enterprise solutions has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 14.2% over the last 60 days.

Penguin Solutions, Inc. Price and Consensus

Penguin Solutions, Inc. price-consensus-chart | Penguin Solutions, Inc. Quote

Penguin’s shares gained 41.2% over the last three months compared with the S&P 500’s advance of 16%. The company possesses a Momentum Score of A.

Penguin Solutions, Inc. Price

Penguin Solutions, Inc. price | Penguin Solutions, Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research